Thromb Haemost 1997; 77(01): 223-224
DOI: 10.1055/s-0038-1655941
Letter to the Editor
Schattauer GmbH Stuttgart

Ticlopidine Antagonizes Acenocoumarol Treatment

A Salar
Department of Haemostasis, Hematology Service, Hospital de Bellvitge “Príncipes de España”, Barcelona, Spain
,
P Domenech
Department of Haemostasis, Hematology Service, Hospital de Bellvitge “Príncipes de España”, Barcelona, Spain
,
F Martínez
Department of Haemostasis, Hematology Service, Hospital de Bellvitge “Príncipes de España”, Barcelona, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 08. Januar 1996

Accepted after revision 05. September 1996

Publikationsdatum:
11. Juli 2018 (online)

 
  • References

  • 1 Cannegieter SC, Rosendaal FR, Wintzen AR, Van derMeer FJM, Vanden-broucke JP, Briët E. Optimal anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-17
  • 2 Israel D, Sharma S, Fuster V. Antithrombotic therapy in prosthetic heart valve replacement. Am Heart J 1994; 127: 400-411
  • 3 Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipiridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541
  • 4 Turpie AG, Gent MG, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329: 524-529
  • 5 Gidal BE, Sorkness CA, McGill KA, Larson R, Levine RR. Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients. Ther Drug Monit 1995; 17: 33-38